This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Xenios Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Francesco Mantegazza: Innovator in Extracorporeal Circulation Systems
Introduction
Francesco Mantegazza is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical technology, particularly in the development of extracorporeal circulation systems. With a total of 2 patents to his name, Mantegazza's work focuses on improving patient care through innovative solutions.
Latest Patents
Mantegazza's latest patents include a "Regional Ant-coagulation System for an Extracorporeal Circulation Circuit." This invention addresses the need for effective blood coagulation management during extracorporeal procedures. The system comprises a line for taking blood from the patient, a first filtering unit, and a line for returning the blood, defining a main circuit. Additionally, it features a secondary circuit for the recirculation of plasma water.
Another significant patent is the "Extracorporeal Circuit for CO Removal from Blood." This invention involves a circuit designed to remove carbon dioxide from the blood. It includes a line for taking blood from the patient, a decarboxylation assembly, and a line for returning the blood. The decarboxylation assembly consists of a first filtering unit, an oxygenator, and an electrodialyzer that generates both an acid solution and a basic solution.
Career Highlights
Francesco Mantegazza is currently associated with Xenios AG, a company that specializes in advanced medical technologies. His work at Xenios AG has allowed him to focus on developing innovative solutions that enhance patient outcomes in critical care settings.
Collaborations
Mantegazza has collaborated with notable colleagues such as Antonio Maria Pesenti and Alberto Zanella. These collaborations have contributed to the advancement of medical technologies and the successful development of his patents.
Conclusion
Francesco Mantegazza is a distinguished inventor whose work in extracorporeal circulation systems has the potential to significantly impact patient care. His innovative patents reflect his commitment to improving medical technology and enhancing the quality of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
